1 | types | 14,121 |
2 | kinds | 1,242 |
3 | sorts | 56 |
4 | fourths | 25 |
5 | topographies | 15 |
6 | availabilities | 7 |
7 | subdimensions | 7 |
8 | patterns/syndromes | 5 |
9 | compability | 4 |
10 | grammages | 4 |
11 | subdoses | 4 |
12 | typings | 4 |
13 | c-factors | 3 |
14 | cldhs | 3 |
15 | clusterings | 3 |
16 | dose-groups | 3 |
17 | germplasms | 3 |
18 | hpv-types | 3 |
19 | studies.none | 3 |
20 | submodalities | 3 |
21 | aplastidic | 2 |
22 | classes/types | 2 |
23 | coinheritance | 2 |
24 | consulates | 2 |
25 | disclocation | 2 |
26 | fluoquinolones | 2 |
27 | mid-points | 2 |
28 | path-stages | 2 |
29 | routes-of-entry | 2 |
30 | shu-points | 2 |
31 | sub-bands | 2 |
32 | 'bodies | 1 |
33 | 'cultures | 1 |
34 | 2-acetamido-3-mercapto-3-methyl-n-aryl-butanamides | 1 |
35 | 3-oxo-3-aryl-2-arylhydrazonopropanals | 1 |
36 | 5'hps | 1 |
37 | antihyperanalgesic | 1 |
38 | aplications | 1 |
39 | areas-control | 1 |
40 | areas-definition | 1 |
41 | aromaticities-benzene | 1 |
42 | arynophiles | 1 |
43 | aspects-establishment | 1 |
44 | av-intervals | 1 |
45 | bp-groups | 1 |
46 | cohorts-users | 1 |
47 | component-processes | 1 |
48 | component/phase | 1 |
49 | conccentrations | 1 |
50 | conditions-avss | 1 |
51 | cryomethods | 1 |
52 | dabs | 1 |
53 | days.intensity | 1 |
54 | design-two-period | 1 |
55 | dose/regimens | 1 |
56 | doses/types | 1 |
57 | duration/dosage | 1 |
58 | endo-knives | 1 |
59 | ethryopathogeneses | 1 |
60 | extrolites | 1 |
61 | f-lpfgs | 1 |
62 | fe-precipitates | 1 |
63 | fluconazole-sensitive | 1 |
64 | fluidifiers | 1 |
65 | gena | 1 |
66 | ghr-isoforms | 1 |
67 | gtfts | 1 |
68 | information-such | 1 |
69 | ingrediants | 1 |
70 | intervention-groups | 1 |
71 | knids | 1 |
72 | level/form | 1 |
73 | lithofacies | 1 |
74 | materials-aluminum | 1 |
75 | methodology.an | 1 |
76 | mmp-knockout | 1 |
77 | motablism | 1 |
78 | nitroheterocycles | 1 |
79 | oh-positions | 1 |
80 | pam-agonist | 1 |
81 | parameters-control | 1 |
82 | phenophases | 1 |
83 | ponderance | 1 |
84 | positions-horizontal | 1 |
85 | premedication-schedules | 1 |
86 | radiation-doses | 1 |
87 | refractiveness | 1 |
88 | sharirika | 1 |
89 | slice-thicknesses | 1 |
90 | socie-ties | 1 |
91 | sociodemograhics | 1 |
92 | solutions/ointments | 1 |
93 | specialties/centres | 1 |
94 | studies.effects | 1 |
95 | studies.therefore | 1 |
96 | sub-zones | 1 |
97 | taches | 1 |
98 | tempi | 1 |
99 | time-horizons | 1 |
100 | tracing-methods | 1 |
101 | transplant- | 1 |
102 | trials.reporting | 1 |
103 | types/sizes | 1 |
104 | vaginitidies | 1 |
105 | varietiest | 1 |
106 | vvds | 1 |
107 | β-ketones | 1 |
1 | 'bodies | 1 |
2 | 'cultures | 1 |
3 | 2-acetamido-3-mercapto-3-methyl-n-aryl-butanamides | 1 |
4 | 3-oxo-3-aryl-2-arylhydrazonopropanals | 1 |
5 | 5'hps | 1 |
6 | antihyperanalgesic | 1 |
7 | aplastidic | 2 |
8 | aplications | 1 |
9 | areas-control | 1 |
10 | areas-definition | 1 |
11 | aromaticities-benzene | 1 |
12 | arynophiles | 1 |
13 | aspects-establishment | 1 |
14 | av-intervals | 1 |
15 | availabilities | 7 |
16 | bp-groups | 1 |
17 | c-factors | 3 |
18 | classes/types | 2 |
19 | cldhs | 3 |
20 | clusterings | 3 |
21 | cohorts-users | 1 |
22 | coinheritance | 2 |
23 | compability | 4 |
24 | component-processes | 1 |
25 | component/phase | 1 |
26 | conccentrations | 1 |
27 | conditions-avss | 1 |
28 | consulates | 2 |
29 | cryomethods | 1 |
30 | dabs | 1 |
31 | days.intensity | 1 |
32 | design-two-period | 1 |
33 | disclocation | 2 |
34 | dose-groups | 3 |
35 | dose/regimens | 1 |
36 | doses/types | 1 |
37 | duration/dosage | 1 |
38 | endo-knives | 1 |
39 | ethryopathogeneses | 1 |
40 | extrolites | 1 |
41 | f-lpfgs | 1 |
42 | fe-precipitates | 1 |
43 | fluconazole-sensitive | 1 |
44 | fluidifiers | 1 |
45 | fluoquinolones | 2 |
46 | fourths | 25 |
47 | gena | 1 |
48 | germplasms | 3 |
49 | ghr-isoforms | 1 |
50 | grammages | 4 |
51 | gtfts | 1 |
52 | hpv-types | 3 |
53 | information-such | 1 |
54 | ingrediants | 1 |
55 | intervention-groups | 1 |
56 | kinds | 1,242 |
57 | knids | 1 |
58 | level/form | 1 |
59 | lithofacies | 1 |
60 | materials-aluminum | 1 |
61 | methodology.an | 1 |
62 | mid-points | 2 |
63 | mmp-knockout | 1 |
64 | motablism | 1 |
65 | nitroheterocycles | 1 |
66 | oh-positions | 1 |
67 | pam-agonist | 1 |
68 | parameters-control | 1 |
69 | path-stages | 2 |
70 | patterns/syndromes | 5 |
71 | phenophases | 1 |
72 | ponderance | 1 |
73 | positions-horizontal | 1 |
74 | premedication-schedules | 1 |
75 | radiation-doses | 1 |
76 | refractiveness | 1 |
77 | routes-of-entry | 2 |
78 | sharirika | 1 |
79 | shu-points | 2 |
80 | slice-thicknesses | 1 |
81 | socie-ties | 1 |
82 | sociodemograhics | 1 |
83 | solutions/ointments | 1 |
84 | sorts | 56 |
85 | specialties/centres | 1 |
86 | studies.effects | 1 |
87 | studies.none | 3 |
88 | studies.therefore | 1 |
89 | sub-bands | 2 |
90 | sub-zones | 1 |
91 | subdimensions | 7 |
92 | subdoses | 4 |
93 | submodalities | 3 |
94 | taches | 1 |
95 | tempi | 1 |
96 | time-horizons | 1 |
97 | topographies | 15 |
98 | tracing-methods | 1 |
99 | transplant- | 1 |
100 | trials.reporting | 1 |
101 | types | 14,121 |
102 | types/sizes | 1 |
103 | typings | 4 |
104 | vaginitidies | 1 |
105 | varietiest | 1 |
106 | vvds | 1 |
107 | β-ketones | 1 |
1 | transplant- | 1 |
2 | sharirika | 1 |
3 | gena | 1 |
4 | aplastidic | 2 |
5 | antihyperanalgesic | 1 |
6 | design-two-period | 1 |
7 | ponderance | 1 |
8 | coinheritance | 2 |
9 | duration/dosage | 1 |
10 | aromaticities-benzene | 1 |
11 | studies.none | 3 |
12 | studies.therefore | 1 |
13 | component/phase | 1 |
14 | fluconazole-sensitive | 1 |
15 | trials.reporting | 1 |
16 | information-such | 1 |
17 | tempi | 1 |
18 | positions-horizontal | 1 |
19 | areas-control | 1 |
20 | parameters-control | 1 |
21 | level/form | 1 |
22 | motablism | 1 |
23 | materials-aluminum | 1 |
24 | methodology.an | 1 |
25 | disclocation | 2 |
26 | areas-definition | 1 |
27 | dabs | 1 |
28 | sociodemograhics | 1 |
29 | knids | 1 |
30 | sub-bands | 2 |
31 | kinds | 1,242 |
32 | tracing-methods | 1 |
33 | cryomethods | 1 |
34 | vvds | 1 |
35 | 2-acetamido-3-mercapto-3-methyl-n-aryl-butanamides | 1 |
36 | grammages | 4 |
37 | path-stages | 2 |
38 | taches | 1 |
39 | lithofacies | 1 |
40 | vaginitidies | 1 |
41 | 'bodies | 1 |
42 | topographies | 15 |
43 | socie-ties | 1 |
44 | submodalities | 3 |
45 | availabilities | 7 |
46 | nitroheterocycles | 1 |
47 | arynophiles | 1 |
48 | premedication-schedules | 1 |
49 | patterns/syndromes | 5 |
50 | fluoquinolones | 2 |
51 | β-ketones | 1 |
52 | sub-zones | 1 |
53 | types | 14,121 |
54 | hpv-types | 3 |
55 | doses/types | 1 |
56 | classes/types | 2 |
57 | specialties/centres | 1 |
58 | 'cultures | 1 |
59 | phenophases | 1 |
60 | ethryopathogeneses | 1 |
61 | radiation-doses | 1 |
62 | subdoses | 4 |
63 | component-processes | 1 |
64 | slice-thicknesses | 1 |
65 | consulates | 2 |
66 | fe-precipitates | 1 |
67 | extrolites | 1 |
68 | endo-knives | 1 |
69 | types/sizes | 1 |
70 | f-lpfgs | 1 |
71 | typings | 4 |
72 | clusterings | 3 |
73 | cldhs | 3 |
74 | fourths | 25 |
75 | 3-oxo-3-aryl-2-arylhydrazonopropanals | 1 |
76 | av-intervals | 1 |
77 | ghr-isoforms | 1 |
78 | germplasms | 3 |
79 | dose/regimens | 1 |
80 | subdimensions | 7 |
81 | aplications | 1 |
82 | conccentrations | 1 |
83 | oh-positions | 1 |
84 | time-horizons | 1 |
85 | 5'hps | 1 |
86 | dose-groups | 3 |
87 | intervention-groups | 1 |
88 | bp-groups | 1 |
89 | fluidifiers | 1 |
90 | cohorts-users | 1 |
91 | c-factors | 3 |
92 | refractiveness | 1 |
93 | conditions-avss | 1 |
94 | studies.effects | 1 |
95 | gtfts | 1 |
96 | ingrediants | 1 |
97 | solutions/ointments | 1 |
98 | mid-points | 2 |
99 | shu-points | 2 |
100 | sorts | 56 |
101 | aspects-establishment | 1 |
102 | varietiest | 1 |
103 | pam-agonist | 1 |
104 | mmp-knockout | 1 |
105 | routes-of-entry | 2 |
106 | compability | 4 |
107 | days.intensity | 1 |